AMS.L
Advanced Medical Solutions Group plc
LSEGBpEQUITY
Healthcare
DELAYED
Last price
281.50
■ 0.00 (0.00%)
MARKET · —
Price
Open
281.03
Prev close
281.50
Day high
281.52
Day low
281.00
Volume
2.55M
Market cap
$612.56M
P/E (TTM)
56.30
52W range
187.00 – 284.50
Trailing performance
Returnvs SPY
1W
+0.18%
+1.5%
1M
+0.36%
-3.4%
3M
+32.47%
+29.4%
6M
+32.47%
+21.4%
YTD
+29.13%
+16.8%
1Y
+35.34%
+15.3%
3Y
+11.71%
-62.5%
5Y
+6.03%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$612.56M
Enterprise value$671.75M
Revenue (TTM)$228.94M
Gross profit$122.14M
EBITDA$37.04M
Net income$9.95M
EPS (TTM)$0.05
Free cash flow$11.26M
Total cash$18.02M
Total debt$81.52M
Book value / share$1.20
Shares outstanding217.60M
Float189.85M
Short % of float—
Dividend yield1.02%
Beta (5Y)0.70
Valuation & profitability ratios
Trailing P/E56.30
Forward P/E16.60
PEG ratio4.74
Price / sales—
Price / book234.39
EV / revenue2.93
EV / EBITDA18.13
Gross margin53.35%
Operating margin10.10%
Profit margin4.35%
Return on equity4.03%
Return on assets3.62%
Debt / equity31.34
Current ratio2.79
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $228.94M | $177.52M | $126.21M | $124.33M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $9.95M | $7.09M | $15.89M | $20.41M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $9.95M | $7.09M | $15.89M | $20.41M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 0.14 | 7 | $246.07M | +7.5% |
| Next year | 0.17 | 7 | $264.08M | +7.3% |
Analyst targets & ownership
Mean target$290.00
High target$325.00
Low target$275.00
Implied upside3.02%
Analyst count7
ConsensusNONE
Strong buy / Buy1 / 4
Hold3
Sell / Strong sell0 / 0
Held by insiders7.75%
Held by institutions77.05%
Institutions holding97
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
16.70M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | Societe Generale Asset Management (France) |
BUY | 402.92K | $1.51M | Direct |
| Aug 19, 26 | Octopus Investments Ltd |
SELL | 190.91K | $716.30K | Direct |
| Aug 19, 26 | Hargreave Hale Ltd |
SELL | 6.64K | $24.93K | Direct |
| Aug 19, 26 | Barclays, Plc. |
INCREASE | 26.96K | $101.16K | Direct |
| Aug 18, 26 | Barclays, Plc. |
BUY | 117.74K | $441.77K | Direct |
| Aug 18, 26 | Barclays, Plc. |
SELL | 109.41K | $410.49K | Direct |
| Aug 18, 26 | Hargreave Hale Ltd |
SELL | 1.43K | $5.35K | Direct |
| Aug 18, 26 | Jefferies International, Ltd. |
BUY | 57.35K | $215.16K | Direct |
| Aug 18, 26 | Jefferies International, Ltd. |
SELL | 102.35K | $384.00K | Direct |
| Aug 18, 26 | Octopus Investments Ltd |
SELL | 17.46K | $65.51K | Direct |
| Aug 17, 26 | Octopus Investments Ltd |
DECREASE | 28.11K | $105.48K | Direct |
| Aug 17, 26 | PSquared Asset Management AG |
SELL | 659.46K | $2.47M | Direct |
| Aug 17, 26 | Societe Generale Asset Management (France) |
BUY | 58.69K | $220.19K | Direct |
| Aug 17, 26 | GAMCO Investors Inc |
— | 0 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Alpine Associates |
— | 7.84M | Bought |
Barclays, Plc. |
— | 6.74M | Increase |
Compagnie Odier SCA |
— | 8.46M | Annual Return |
Hargreave Hale Ltd |
— | 9.47M | Sold |
J.P. Morgan Securities PLC |
— | 8.62M | Holding |
Morgan Stanley & Co International Ltd |
— | 11.34M | Decrease |
Octopus Investments Ltd |
— | 16.67M | Sold |
Sand Grove Capital Management LLP |
— | 6.32M | Sold |
Societe Generale Asset Management (France) |
— | 7.51M | Bought |
Trium Capital LLP |
— | 5.71M | Bought |
Moving averages & technicals
SMA 10
281.25
+0.09% from price
SMA 20
280.85
+0.23% from price
SMA 50
272.16
+3.43% from price
SMA 100
249.87
+12.66% from price
SMA 200
230.89
+21.92% from price
EMA 12
281.07
+0.15% from price
EMA 26
278.66
+1.02% from price
EMA 50
270.23
+4.17% from price
RSI (14)
69.4
Neutral
MACD (12,26,9)
2.41
Hist -0.86
ATR (14)
1.20
0.43% of price
Realised vol 30D
3.1%
Annualised
Bollinger upper
281.90
20, 2σ
Bollinger lower
279.80
20, 2σ
50 / 200 cross
Golden
272.16 vs 230.89
Trend bias
Above 200
+21.92%
Risk profile
Beta vs SPY
0.14
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
3.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.0%
Peak to trough
Max drawdown 5Y
-48.2%
Peak to trough
ATR 14
1.20
0.43% of price
Beta (reported)
0.70
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Ken de la Bastide column: Residents will be dealing with flooding for years
The Herald Bulletin, Anderson, Ind. · 3m ago
Germany's Merz to press cabinet for faster pro-growth reforms
Reuters · 8m ago
Teen killed at California high school football game; suspect arrested
USA TODAY · 15m ago
Real Madrid snatch late win at Espanyol on Mourinho's return
AFP · 19m ago
Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More
24/7 Wall St. · 20m ago
Maresca says Man City must fill Rodri void after Barca switch
AFP · 24m ago
ASEAN Records and ASIA Records Announce Major Expansion as Verified Record Certification Grows Across Asia
TMX Newsfile · 29m ago
Institutional Investors Are Buying Hyperliquid Strategies. Should You?
Motley Fool · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.